✓ Eligible patients can apply pre-tax HSA or FSA funds

Surgery Is Where The Result Starts

The weeks that follow decide how your work settles, and that stretch has always sat outside your control. The LYMA Laser delivers photobiomodulation at a therapeutic dose, at home, daily, without heat and without adding downtime.
Open to physician practices two ways. Wholesale, where your patient buys from your practice, launching soon. Or our referral program, running now.

✓ Eligible patients can apply pre-tax HSA/FSA funds

Surgery Is Where The Result Starts

Photobiomodulation, at a clinically meaningful dose

Near-infrared light absorbed by cytochrome c oxidase raises
mitochondrial ATP output, which drives fibroblast proliferation and collagen synthesis. The mechanism is well described and has more than 60 years of clinical use behind it.

The constraint has always been dose at depth. Photobiomodulation is biphasic, so an insufficient dose does nothing and an excessive one reverses the effect. Coherent, collimated light holds irradiance as it travels, which is what makes a therapeutic dose at dermal depth achievable in a device a patient can hold.

Wavelength

808nm near-infrared

Source

Coherent laser diode

Irradiance

[mW/cm2 to confirm]

Fluence per treatment area

[J/cm2 to confirm]

Treatment time

3 minutes per area

Thermal effect

None

Regulatory

FDA cleared, Class [X]

Photobiomodulation, at a clinically meaningful dose

45 of 107 Genes Altered.
78% Mean Reduction In Wound Area

Gene expression in human skin following 808nm laser and LED exposure, with a companion clinical arm on wound healing.

Led by craniofacial and plastic surgeon Dr. Graeme Glass, published in Aesthetic Surgery Journal Open Forum, 2025.

At matched wavelength, laser exposure altered the expression of 45 of 107 genes involved in skin repair and regeneration, including SIRT1.

LED exposure altered one. The clinical arm showed a 78% mean reduction in wound area.

READ THE PAPER METHODOLOGY AND SAMPLE

45 of 107 Genes Altered. 78% Mean Reduction In Wound Area

Gene expression in human skin following 808nm laser and LED exposure, with a companion clinical arm on wound healing. Led by craniofacial and plastic surgeon Dr. Graeme Glass, published in Aesthetic Surgery Journal Open Forum, 2025. At matched wavelength, laser exposure altered the expression of 45 of 107 genes involved in skin repair and regeneration, including SIRT1. LED exposure altered one. The clinical arm showed a 78% mean reduction in wound area.

READ THE PAPER METHODOLOGY AND SAMPLE

Where it sits in a dermatology practice

Used daily by the patient at home.
Nothing is used in the office, and it asks nothing of your chair time.

$Ablative and fractional resurfacing$

Ablative and fractional resurfacing

Supports re-epithelialization and helps calm inflammation as the skin recovers after ablation.

RF microneedling and microneedling

Complements the fibroblast and collagen response the micro-injuries trigger.

Chemical peels

Supports recovery and helps calm redness through the days after treatment.

Injectables and fillers

Supports the clearance of bruising and swelling around the result.

Acne scarring and post-inflammatory erythema

Supports the appearance of scarring and helps calm persistent redness between sessions.

Protocol and Safety

Two documents for the practice. A one-page protocol setting out when to start after each procedure type, frequency, duration and what to expect at week 2 and week 6. And a one-page safety sheet covering eye protection, photosensitizing medications, active malignancy in the treatment field, and use in pregnancy.

Written to be printed and kept, and shared with the practice before any commercial conversation.

DOWNLOAD THE PROTOCOL DOWNLOAD THE SAFETY SHEET

Two routes. The Difference Is How Your Patient Buys

Practices choose one route or the other rather than both, and nothing is permanent.
Full commercial terms for both routes are shared when you register your interest or apply, and we are glad to talk them through.